Increased lysyl oxidase‐like 2 associates with a poor prognosis in non‐small cell lung cancer

E-ISSN： 1752-699x|12|2|712-720

ISSN： 1752-6981

Source： THE CLINICAL RESPIRATORY JOURNAL, Vol.12, Iss.2, 2018-02, pp. : 712-720

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spotlight on Bevacizumab in Advanced Colorectal Cancer, Breast Cancer, and Non-Small Cell Lung Cancer

By Lyseng-Williamson Katherine A. Robinson Dean M.

BioDrugs, Vol. 20, Iss. 3, 2006-01 ,pp. : 193-195

Adis International

Access to resources Recommend Favorite

Radiochemotherapy for Non Small Cell Lung Cancer

Current Drug Therapy, Vol. 5, Iss. 3, 2010-08 ,pp. : 180-191

Bentham Science Publishers

Access to resources Recommend Favorite

Bevacizumab Plus Platinum-Based Chemotherapy: In Advanced Non-Small Cell Lung Cancer

By Wagstaff Antona J. Keam Susan J. McCormack Paul L.

BioDrugs, Vol. 23, Iss. 3, 2009-06 ,pp. : 187-196

Adis International

Access to resources Recommend Favorite

Diagnosis value of serum soluble B7‐H4 expression in non‐small cell lung cancer

THE CLINICAL RESPIRATORY JOURNAL, Vol. 12, Iss. 1, 2018-01 ,pp. : 134-139

John Wiley & Sons Inc

Access to resources Recommend Favorite

Association of eNOS and ACE gene polymorphisms and plasma nitric oxide with risk of non‐small cell lung cancer in South India

THE CLINICAL RESPIRATORY JOURNAL, Vol. 12, Iss. 1, 2018-01 ,pp. : 207-217

John Wiley & Sons Inc

Access to resources Recommend Favorite